ORTI-A Ortivus AB (publ)

0.1624USD1.650 SEK · STO+24.06%Mkt Cap: 14.39M USDP/E: —

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and EC…

Key Statistics

Company
Market Cap14.39M USD
Enterprise Value16.74M USD
Revenue (TTM)7.52M USD
Gross Profit2.91M USD
Net Income (TTM)-2.15M USD
Revenue/Share0.10 USD
Last Price0.1624 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0000188930
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG4.48
EV/EBITDA-9.33
EV/Revenue2.23
P/S1.91
P/B8.21
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.104330% of range0.3002
52W High0.3002 USD
52W Low0.1043 USD
Profitability
Gross Margin40.33%
Oper. Margin-24.62%
EBITDA Margin-23.87%
Profit Margin-29.80%
ROE-97.60%
ROA-30.84%
ROIC-43.11%
ROCE-35.18%
Growth
Revenue Growth-1.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.48M USD
CapEx (TTM)944.23K USD
FCF Margin-34.29%
FCF Yield-17.92%
Net Debt2.36M USD
Net Debt/EBITDA-1.31
Net Debt/FCF—
Balance Sheet
Debt/Equity0.87
Current Ratio1.08
Quick Ratio0.73
Book Value/Sh0.02 USD
Cash/Share0.0075 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.66M
Float9.15M
Insiders47.99%
Institutions2.43%
Technical
SMA 500.1710 (-5.0%)
SMA 2000.1931 (-15.9%)
Beta0.99
S&P 52W Chg12.00%
Avg Vol (30d)1.98K
Avg Vol (10d)3.44K
Technical Indicators
RSI (14)51.1
MACD-0.0913
MACD Signal-0.0995
MACD Hist.+0.0082
BB Upper0.1983 USD
BB Middle0.1518 USD
BB Lower0.1053 USD
BB Width61.31%
ATR (14)0.0247 USD
Vol Ratio (20d)0.02x

About Ortivus (STO: ORTI-A)

›

Ortivus (STO: ORTI-A) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 1.650 SEK on 19 November 2026, down 40.4% over 52 weeks. Its 52-week range is 1.060 SEK to 3.050 SEK: the price is 45.9% below the high and 55.7% above the low.

Its market capitalisation is 146.21M SEK.

Ortivus reports return on equity of -97.6%, an operating margin of -24.6% and revenue down 1.8% year over year.

Its debt exceeds its cash by 23.93M SEK, a debt-to-equity ratio of 0.87. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.